nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetaminophen—PTGS1—malignant glioma	0.357	0.636	CbGaD
Acetaminophen—PTGS2—malignant glioma	0.204	0.364	CbGaD
Acetaminophen—CYP1A2—Carmustine—malignant glioma	0.0665	0.569	CbGbCtD
Acetaminophen—CYP3A4—Temozolomide—malignant glioma	0.0503	0.43	CbGbCtD
Acetaminophen—NAT2—pineal body—malignant glioma	0.012	0.246	CbGeAlD
Acetaminophen—Alveolitis—Temozolomide—malignant glioma	0.0108	0.104	CcSEcCtD
Acetaminophen—Traumatic liver injury—Temozolomide—malignant glioma	0.00363	0.0349	CcSEcCtD
Acetaminophen—CNR1—telencephalon—malignant glioma	0.00266	0.0546	CbGeAlD
Acetaminophen—Azotaemia—Carmustine—malignant glioma	0.00263	0.0253	CcSEcCtD
Acetaminophen—SULT1A1—telencephalon—malignant glioma	0.00245	0.0502	CbGeAlD
Acetaminophen—Digestion impaired—Temozolomide—malignant glioma	0.00203	0.0195	CcSEcCtD
Acetaminophen—SULT2A1—central nervous system—malignant glioma	0.00175	0.0359	CbGeAlD
Acetaminophen—Injection site pain—Carmustine—malignant glioma	0.00172	0.0165	CcSEcCtD
Acetaminophen—SULT1A1—spinal cord—malignant glioma	0.00171	0.0352	CbGeAlD
Acetaminophen—Liver injury—Temozolomide—malignant glioma	0.00161	0.0155	CcSEcCtD
Acetaminophen—Disturbance in attention—Temozolomide—malignant glioma	0.00156	0.015	CcSEcCtD
Acetaminophen—Drug interaction—Carmustine—malignant glioma	0.00151	0.0145	CcSEcCtD
Acetaminophen—TRPV1—spinal cord—malignant glioma	0.00151	0.031	CbGeAlD
Acetaminophen—CNR1—cerebellum—malignant glioma	0.00148	0.0303	CbGeAlD
Acetaminophen—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00143	0.0138	CcSEcCtD
Acetaminophen—Coordination abnormal—Carmustine—malignant glioma	0.00143	0.0137	CcSEcCtD
Acetaminophen—Injection site reaction—Carmustine—malignant glioma	0.00139	0.0134	CcSEcCtD
Acetaminophen—SULT1A1—central nervous system—malignant glioma	0.00139	0.0285	CbGeAlD
Acetaminophen—SULT2A1—brain—malignant glioma	0.00139	0.0285	CbGeAlD
Acetaminophen—Coordination abnormal—Temozolomide—malignant glioma	0.00138	0.0133	CcSEcCtD
Acetaminophen—SULT1A1—cerebellum—malignant glioma	0.00136	0.0279	CbGeAlD
Acetaminophen—Coma—Carmustine—malignant glioma	0.00128	0.0123	CcSEcCtD
Acetaminophen—TRPV1—central nervous system—malignant glioma	0.00122	0.0251	CbGeAlD
Acetaminophen—CNR1—brain—malignant glioma	0.0012	0.0246	CbGeAlD
Acetaminophen—SULT1A1—brain—malignant glioma	0.0011	0.0227	CbGeAlD
Acetaminophen—Hepatic failure—Temozolomide—malignant glioma	0.00109	0.0105	CcSEcCtD
Acetaminophen—PTGS1—endothelium—malignant glioma	0.00105	0.0216	CbGeAlD
Acetaminophen—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00104	0.01	CcSEcCtD
Acetaminophen—PTGS2—endothelium—malignant glioma	0.001	0.0206	CbGeAlD
Acetaminophen—TRPV1—brain—malignant glioma	0.000971	0.0199	CbGeAlD
Acetaminophen—PTGS1—blood vessel—malignant glioma	0.000969	0.0199	CbGeAlD
Acetaminophen—PTGS2—blood vessel—malignant glioma	0.000926	0.019	CbGeAlD
Acetaminophen—Hypokalaemia—Carmustine—malignant glioma	0.000926	0.0089	CcSEcCtD
Acetaminophen—Muscular weakness—Carmustine—malignant glioma	0.000897	0.00862	CcSEcCtD
Acetaminophen—Hypokalaemia—Temozolomide—malignant glioma	0.000894	0.0086	CcSEcCtD
Acetaminophen—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.000885	0.00851	CcSEcCtD
Acetaminophen—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000885	0.00851	CcSEcCtD
Acetaminophen—Muscular weakness—Temozolomide—malignant glioma	0.000867	0.00833	CcSEcCtD
Acetaminophen—Abdominal distension—Temozolomide—malignant glioma	0.000855	0.00822	CcSEcCtD
Acetaminophen—Pancytopenia—Carmustine—malignant glioma	0.000835	0.00802	CcSEcCtD
Acetaminophen—Sweating increased—Temozolomide—malignant glioma	0.000827	0.00795	CcSEcCtD
Acetaminophen—Neutropenia—Carmustine—malignant glioma	0.000822	0.0079	CcSEcCtD
Acetaminophen—Pancytopenia—Temozolomide—malignant glioma	0.000807	0.00775	CcSEcCtD
Acetaminophen—Dysuria—Temozolomide—malignant glioma	0.000794	0.00763	CcSEcCtD
Acetaminophen—Neutropenia—Temozolomide—malignant glioma	0.000794	0.00763	CcSEcCtD
Acetaminophen—Hyperglycaemia—Carmustine—malignant glioma	0.000793	0.00762	CcSEcCtD
Acetaminophen—Photosensitivity reaction—Temozolomide—malignant glioma	0.000775	0.00745	CcSEcCtD
Acetaminophen—Hyperglycaemia—Temozolomide—malignant glioma	0.000766	0.00737	CcSEcCtD
Acetaminophen—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000751	0.00722	CcSEcCtD
Acetaminophen—Hepatobiliary disease—Temozolomide—malignant glioma	0.000716	0.00689	CcSEcCtD
Acetaminophen—Haemoglobin—Carmustine—malignant glioma	0.000707	0.0068	CcSEcCtD
Acetaminophen—Haemorrhage—Carmustine—malignant glioma	0.000704	0.00676	CcSEcCtD
Acetaminophen—Hallucination—Carmustine—malignant glioma	0.0007	0.00673	CcSEcCtD
Acetaminophen—Oedema peripheral—Carmustine—malignant glioma	0.000693	0.00666	CcSEcCtD
Acetaminophen—Connective tissue disorder—Carmustine—malignant glioma	0.000691	0.00665	CcSEcCtD
Acetaminophen—Haemoglobin—Temozolomide—malignant glioma	0.000683	0.00657	CcSEcCtD
Acetaminophen—Haemorrhage—Temozolomide—malignant glioma	0.00068	0.00654	CcSEcCtD
Acetaminophen—Hepatitis—Temozolomide—malignant glioma	0.00068	0.00654	CcSEcCtD
Acetaminophen—Hallucination—Temozolomide—malignant glioma	0.000676	0.0065	CcSEcCtD
Acetaminophen—Urinary tract disorder—Temozolomide—malignant glioma	0.000671	0.00645	CcSEcCtD
Acetaminophen—Oedema peripheral—Temozolomide—malignant glioma	0.00067	0.00644	CcSEcCtD
Acetaminophen—Connective tissue disorder—Temozolomide—malignant glioma	0.000668	0.00642	CcSEcCtD
Acetaminophen—Urethral disorder—Temozolomide—malignant glioma	0.000666	0.00641	CcSEcCtD
Acetaminophen—Eye disorder—Carmustine—malignant glioma	0.000657	0.00632	CcSEcCtD
Acetaminophen—Flushing—Carmustine—malignant glioma	0.000653	0.00628	CcSEcCtD
Acetaminophen—Erythema multiforme—Temozolomide—malignant glioma	0.000643	0.00618	CcSEcCtD
Acetaminophen—Eye disorder—Temozolomide—malignant glioma	0.000635	0.00611	CcSEcCtD
Acetaminophen—Cardiac disorder—Temozolomide—malignant glioma	0.000631	0.00607	CcSEcCtD
Acetaminophen—Flushing—Temozolomide—malignant glioma	0.000631	0.00607	CcSEcCtD
Acetaminophen—Angiopathy—Temozolomide—malignant glioma	0.000617	0.00593	CcSEcCtD
Acetaminophen—Mental disorder—Carmustine—malignant glioma	0.000616	0.00592	CcSEcCtD
Acetaminophen—Immune system disorder—Temozolomide—malignant glioma	0.000614	0.0059	CcSEcCtD
Acetaminophen—Mediastinal disorder—Temozolomide—malignant glioma	0.000613	0.00589	CcSEcCtD
Acetaminophen—Malnutrition—Carmustine—malignant glioma	0.000612	0.00589	CcSEcCtD
Acetaminophen—Erythema—Carmustine—malignant glioma	0.000612	0.00589	CcSEcCtD
Acetaminophen—Chills—Temozolomide—malignant glioma	0.00061	0.00586	CcSEcCtD
Acetaminophen—SLC22A6—brain—malignant glioma	0.000597	0.0123	CbGeAlD
Acetaminophen—Mental disorder—Temozolomide—malignant glioma	0.000596	0.00573	CcSEcCtD
Acetaminophen—Malnutrition—Temozolomide—malignant glioma	0.000592	0.00569	CcSEcCtD
Acetaminophen—Erythema—Temozolomide—malignant glioma	0.000592	0.00569	CcSEcCtD
Acetaminophen—Vision blurred—Carmustine—malignant glioma	0.000577	0.00555	CcSEcCtD
Acetaminophen—Tremor—Carmustine—malignant glioma	0.000574	0.00552	CcSEcCtD
Acetaminophen—CYP2A6—cerebellum—malignant glioma	0.000574	0.0118	CbGeAlD
Acetaminophen—ABCB1—blood vessel—malignant glioma	0.000573	0.0118	CbGeAlD
Acetaminophen—Anaemia—Carmustine—malignant glioma	0.000566	0.00544	CcSEcCtD
Acetaminophen—Agitation—Carmustine—malignant glioma	0.000563	0.00541	CcSEcCtD
Acetaminophen—Vision blurred—Temozolomide—malignant glioma	0.000558	0.00536	CcSEcCtD
Acetaminophen—Tremor—Temozolomide—malignant glioma	0.000554	0.00533	CcSEcCtD
Acetaminophen—PTGS2—embryo—malignant glioma	0.000553	0.0113	CbGeAlD
Acetaminophen—Ill-defined disorder—Temozolomide—malignant glioma	0.000549	0.00528	CcSEcCtD
Acetaminophen—Leukopenia—Carmustine—malignant glioma	0.000548	0.00527	CcSEcCtD
Acetaminophen—Anaemia—Temozolomide—malignant glioma	0.000547	0.00526	CcSEcCtD
Acetaminophen—Agitation—Temozolomide—malignant glioma	0.000544	0.00523	CcSEcCtD
Acetaminophen—Angioedema—Temozolomide—malignant glioma	0.000541	0.0052	CcSEcCtD
Acetaminophen—Malaise—Temozolomide—malignant glioma	0.000534	0.00513	CcSEcCtD
Acetaminophen—Convulsion—Carmustine—malignant glioma	0.000531	0.0051	CcSEcCtD
Acetaminophen—Leukopenia—Temozolomide—malignant glioma	0.00053	0.00509	CcSEcCtD
Acetaminophen—Hypertension—Carmustine—malignant glioma	0.000529	0.00508	CcSEcCtD
Acetaminophen—Palpitations—Temozolomide—malignant glioma	0.000523	0.00503	CcSEcCtD
Acetaminophen—Chest pain—Carmustine—malignant glioma	0.000521	0.00501	CcSEcCtD
Acetaminophen—Anxiety—Carmustine—malignant glioma	0.00052	0.00499	CcSEcCtD
Acetaminophen—Cough—Temozolomide—malignant glioma	0.000516	0.00496	CcSEcCtD
Acetaminophen—Convulsion—Temozolomide—malignant glioma	0.000513	0.00493	CcSEcCtD
Acetaminophen—Hypertension—Temozolomide—malignant glioma	0.000511	0.00491	CcSEcCtD
Acetaminophen—Confusional state—Carmustine—malignant glioma	0.000504	0.00484	CcSEcCtD
Acetaminophen—Anxiety—Temozolomide—malignant glioma	0.000502	0.00483	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.0005	0.00481	CcSEcCtD
Acetaminophen—Oedema—Carmustine—malignant glioma	0.0005	0.0048	CcSEcCtD
Acetaminophen—Discomfort—Temozolomide—malignant glioma	0.000498	0.00479	CcSEcCtD
Acetaminophen—Dry mouth—Temozolomide—malignant glioma	0.000493	0.00474	CcSEcCtD
Acetaminophen—Thrombocytopenia—Carmustine—malignant glioma	0.000489	0.0047	CcSEcCtD
Acetaminophen—CYP2E1—telencephalon—malignant glioma	0.000488	0.01	CbGeAlD
Acetaminophen—Tachycardia—Carmustine—malignant glioma	0.000488	0.00469	CcSEcCtD
Acetaminophen—Confusional state—Temozolomide—malignant glioma	0.000487	0.00468	CcSEcCtD
Acetaminophen—Oedema—Temozolomide—malignant glioma	0.000483	0.00464	CcSEcCtD
Acetaminophen—Anaphylactic shock—Temozolomide—malignant glioma	0.000483	0.00464	CcSEcCtD
Acetaminophen—Anorexia—Carmustine—malignant glioma	0.000476	0.00458	CcSEcCtD
Acetaminophen—Nervous system disorder—Temozolomide—malignant glioma	0.000474	0.00455	CcSEcCtD
Acetaminophen—Thrombocytopenia—Temozolomide—malignant glioma	0.000473	0.00455	CcSEcCtD
Acetaminophen—PTGS1—telencephalon—malignant glioma	0.00047	0.00965	CbGeAlD
Acetaminophen—Skin disorder—Temozolomide—malignant glioma	0.000469	0.00451	CcSEcCtD
Acetaminophen—Hypotension—Carmustine—malignant glioma	0.000467	0.00449	CcSEcCtD
Acetaminophen—Hyperhidrosis—Temozolomide—malignant glioma	0.000467	0.00449	CcSEcCtD
Acetaminophen—CYP2A6—brain—malignant glioma	0.000466	0.00957	CbGeAlD
Acetaminophen—Anorexia—Temozolomide—malignant glioma	0.00046	0.00443	CcSEcCtD
Acetaminophen—Insomnia—Carmustine—malignant glioma	0.000452	0.00435	CcSEcCtD
Acetaminophen—PTGS2—telencephalon—malignant glioma	0.000449	0.00923	CbGeAlD
Acetaminophen—Dyspnoea—Carmustine—malignant glioma	0.000446	0.00428	CcSEcCtD
Acetaminophen—Somnolence—Carmustine—malignant glioma	0.000444	0.00427	CcSEcCtD
Acetaminophen—Insomnia—Temozolomide—malignant glioma	0.000437	0.0042	CcSEcCtD
Acetaminophen—CYP2D6—brainstem—malignant glioma	0.000435	0.00894	CbGeAlD
Acetaminophen—Decreased appetite—Carmustine—malignant glioma	0.000434	0.00418	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Carmustine—malignant glioma	0.000432	0.00415	CcSEcCtD
Acetaminophen—Dyspnoea—Temozolomide—malignant glioma	0.000431	0.00414	CcSEcCtD
Acetaminophen—Somnolence—Temozolomide—malignant glioma	0.000429	0.00413	CcSEcCtD
Acetaminophen—Constipation—Carmustine—malignant glioma	0.000427	0.00411	CcSEcCtD
Acetaminophen—Dyspepsia—Temozolomide—malignant glioma	0.000425	0.00409	CcSEcCtD
Acetaminophen—Decreased appetite—Temozolomide—malignant glioma	0.00042	0.00404	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000417	0.00401	CcSEcCtD
Acetaminophen—Fatigue—Temozolomide—malignant glioma	0.000416	0.004	CcSEcCtD
Acetaminophen—Constipation—Temozolomide—malignant glioma	0.000413	0.00397	CcSEcCtD
Acetaminophen—Feeling abnormal—Carmustine—malignant glioma	0.000412	0.00396	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Carmustine—malignant glioma	0.000409	0.00393	CcSEcCtD
Acetaminophen—Feeling abnormal—Temozolomide—malignant glioma	0.000398	0.00383	CcSEcCtD
Acetaminophen—Abdominal pain—Carmustine—malignant glioma	0.000395	0.0038	CcSEcCtD
Acetaminophen—Body temperature increased—Carmustine—malignant glioma	0.000395	0.0038	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Temozolomide—malignant glioma	0.000395	0.0038	CcSEcCtD
Acetaminophen—CYP2D6—telencephalon—malignant glioma	0.000386	0.00793	CbGeAlD
Acetaminophen—Urticaria—Temozolomide—malignant glioma	0.000384	0.00369	CcSEcCtD
Acetaminophen—CYP2E1—medulla oblongata—malignant glioma	0.000383	0.00787	CbGeAlD
Acetaminophen—Abdominal pain—Temozolomide—malignant glioma	0.000382	0.00367	CcSEcCtD
Acetaminophen—Body temperature increased—Temozolomide—malignant glioma	0.000382	0.00367	CcSEcCtD
Acetaminophen—Hypersensitivity—Carmustine—malignant glioma	0.000368	0.00354	CcSEcCtD
Acetaminophen—Asthenia—Carmustine—malignant glioma	0.000359	0.00345	CcSEcCtD
Acetaminophen—Hypersensitivity—Temozolomide—malignant glioma	0.000356	0.00342	CcSEcCtD
Acetaminophen—PTGS2—medulla oblongata—malignant glioma	0.000353	0.00725	CbGeAlD
Acetaminophen—Asthenia—Temozolomide—malignant glioma	0.000347	0.00333	CcSEcCtD
Acetaminophen—Diarrhoea—Carmustine—malignant glioma	0.000342	0.00329	CcSEcCtD
Acetaminophen—CYP2E1—spinal cord—malignant glioma	0.000342	0.00702	CbGeAlD
Acetaminophen—ABCB1—embryo—malignant glioma	0.000342	0.00702	CbGeAlD
Acetaminophen—Pruritus—Temozolomide—malignant glioma	0.000342	0.00328	CcSEcCtD
Acetaminophen—Dizziness—Carmustine—malignant glioma	0.000331	0.00318	CcSEcCtD
Acetaminophen—Diarrhoea—Temozolomide—malignant glioma	0.00033	0.00318	CcSEcCtD
Acetaminophen—PTGS1—spinal cord—malignant glioma	0.000329	0.00676	CbGeAlD
Acetaminophen—PTGS2—midbrain—malignant glioma	0.000323	0.00663	CbGeAlD
Acetaminophen—Dizziness—Temozolomide—malignant glioma	0.000319	0.00307	CcSEcCtD
Acetaminophen—Vomiting—Carmustine—malignant glioma	0.000318	0.00305	CcSEcCtD
Acetaminophen—Rash—Carmustine—malignant glioma	0.000315	0.00303	CcSEcCtD
Acetaminophen—Dermatitis—Carmustine—malignant glioma	0.000315	0.00303	CcSEcCtD
Acetaminophen—PTGS2—spinal cord—malignant glioma	0.000315	0.00646	CbGeAlD
Acetaminophen—Headache—Carmustine—malignant glioma	0.000313	0.00301	CcSEcCtD
Acetaminophen—Vomiting—Temozolomide—malignant glioma	0.000307	0.00295	CcSEcCtD
Acetaminophen—Rash—Temozolomide—malignant glioma	0.000305	0.00293	CcSEcCtD
Acetaminophen—Dermatitis—Temozolomide—malignant glioma	0.000304	0.00292	CcSEcCtD
Acetaminophen—CYP1A1—central nervous system—malignant glioma	0.000304	0.00625	CbGeAlD
Acetaminophen—Headache—Temozolomide—malignant glioma	0.000303	0.00291	CcSEcCtD
Acetaminophen—ABCB1—retina—malignant glioma	0.000302	0.0062	CbGeAlD
Acetaminophen—Nausea—Carmustine—malignant glioma	0.000297	0.00285	CcSEcCtD
Acetaminophen—Nausea—Temozolomide—malignant glioma	0.000287	0.00276	CcSEcCtD
Acetaminophen—ABCB1—telencephalon—malignant glioma	0.000278	0.00571	CbGeAlD
Acetaminophen—CYP2E1—central nervous system—malignant glioma	0.000277	0.0057	CbGeAlD
Acetaminophen—CYP2E1—cerebellum—malignant glioma	0.000271	0.00557	CbGeAlD
Acetaminophen—PTGS1—central nervous system—malignant glioma	0.000267	0.00549	CbGeAlD
Acetaminophen—CYP2C8—brain—malignant glioma	0.000262	0.00537	CbGeAlD
Acetaminophen—PTGS2—central nervous system—malignant glioma	0.000255	0.00524	CbGeAlD
Acetaminophen—PTGS2—cerebellum—malignant glioma	0.00025	0.00513	CbGeAlD
Acetaminophen—CYP1A1—brain—malignant glioma	0.000241	0.00496	CbGeAlD
Acetaminophen—CYP3A4—central nervous system—malignant glioma	0.000223	0.00458	CbGeAlD
Acetaminophen—CYP2E1—brain—malignant glioma	0.00022	0.00452	CbGeAlD
Acetaminophen—CYP2D6—central nervous system—malignant glioma	0.00022	0.00451	CbGeAlD
Acetaminophen—ABCB1—medulla oblongata—malignant glioma	0.000218	0.00448	CbGeAlD
Acetaminophen—CYP2D6—cerebellum—malignant glioma	0.000215	0.00441	CbGeAlD
Acetaminophen—PTGS1—brain—malignant glioma	0.000212	0.00436	CbGeAlD
Acetaminophen—PTGS2—brain—malignant glioma	0.000203	0.00416	CbGeAlD
Acetaminophen—ABCB1—midbrain—malignant glioma	0.0002	0.0041	CbGeAlD
Acetaminophen—ABCB1—spinal cord—malignant glioma	0.000195	0.004	CbGeAlD
Acetaminophen—CYP2D6—brain—malignant glioma	0.000174	0.00358	CbGeAlD
Acetaminophen—ABCB1—central nervous system—malignant glioma	0.000158	0.00324	CbGeAlD
Acetaminophen—ABCB1—cerebellum—malignant glioma	0.000154	0.00317	CbGeAlD
Acetaminophen—ABCB1—brain—malignant glioma	0.000125	0.00258	CbGeAlD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.1e-05	6.45e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—CYP2B6—malignant glioma	1.09e-05	6.43e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—CAT—malignant glioma	1.09e-05	6.4e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—NCOR1—malignant glioma	1.09e-05	6.4e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—CAV1—malignant glioma	1.09e-05	6.4e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—CAV1—malignant glioma	1.09e-05	6.4e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CDKN2B—malignant glioma	1.09e-05	6.39e-05	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—AKT1—malignant glioma	1.09e-05	6.39e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—BCHE—malignant glioma	1.05e-05	6.16e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.05e-05	6.15e-05	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—PIK3CA—malignant glioma	1.04e-05	6.14e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.04e-05	6.11e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—HES1—malignant glioma	1.04e-05	6.1e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—SLC5A5—malignant glioma	1.03e-05	6.09e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PTGS1—malignant glioma	1.03e-05	6.08e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—NCOR1—malignant glioma	1.03e-05	6.06e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.03e-05	6.06e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—NCOR1—malignant glioma	1.03e-05	6.05e-05	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—PIK3CA—malignant glioma	1.03e-05	6.03e-05	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—AKT1—malignant glioma	1.02e-05	6.01e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—IDH1—malignant glioma	1e-05	5.88e-05	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—TP53—malignant glioma	9.92e-06	5.84e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PIK3CG—malignant glioma	9.9e-06	5.83e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PIK3CG—malignant glioma	9.9e-06	5.83e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—PDGFRA—malignant glioma	9.86e-06	5.81e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	9.78e-06	5.76e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.69e-06	5.7e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—SPHK1—malignant glioma	9.67e-06	5.69e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—GSTT1—malignant glioma	9.6e-06	5.65e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—BCHE—malignant glioma	9.6e-06	5.65e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PPARG—malignant glioma	9.55e-06	5.62e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PPARG—malignant glioma	9.55e-06	5.62e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	9.53e-06	5.61e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.52e-06	5.61e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—SLC5A5—malignant glioma	9.48e-06	5.58e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—CYP2C18—malignant glioma	9.48e-06	5.58e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—GSTP1—malignant glioma	9.39e-06	5.52e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	9.32e-06	5.48e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	9.19e-06	5.41e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—CAT—malignant glioma	9.14e-06	5.38e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—TERT—malignant glioma	9.08e-06	5.34e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—HLA-A—malignant glioma	9.08e-06	5.34e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—GSTT1—malignant glioma	9.05e-06	5.32e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PTGS1—malignant glioma	9e-06	5.29e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—IDH2—malignant glioma	8.97e-06	5.28e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—GSTT1—malignant glioma	8.97e-06	5.28e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.97e-06	5.28e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	8.94e-06	5.26e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.89e-06	5.23e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—PDGFB—malignant glioma	8.86e-06	5.21e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—CAV1—malignant glioma	8.86e-06	5.21e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—GSTP1—malignant glioma	8.84e-06	5.2e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—FGFR1—malignant glioma	8.82e-06	5.19e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PIK3CD—malignant glioma	8.7e-06	5.12e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PIK3CD—malignant glioma	8.7e-06	5.12e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—HIF1A—malignant glioma	8.68e-06	5.11e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—NCOR1—malignant glioma	8.63e-06	5.08e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—CAT—malignant glioma	8.6e-06	5.06e-05	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—AKT1—malignant glioma	8.52e-06	5.01e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PTGS1—malignant glioma	8.48e-06	4.99e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.46e-06	4.98e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.45e-06	4.97e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CYP2B6—malignant glioma	8.44e-06	4.96e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PTGS1—malignant glioma	8.4e-06	4.95e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CAV1—malignant glioma	8.4e-06	4.94e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—CAV1—malignant glioma	8.38e-06	4.93e-05	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—AKT1—malignant glioma	8.38e-06	4.93e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	8.37e-06	4.93e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—BCHE—malignant glioma	8.36e-06	4.92e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—GSTP1—malignant glioma	8.33e-06	4.9e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—SLC5A5—malignant glioma	8.26e-06	4.86e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	8.14e-06	4.79e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—NCOR1—malignant glioma	8.12e-06	4.78e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—CAT—malignant glioma	8.11e-06	4.77e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PIK3CG—malignant glioma	8.07e-06	4.75e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—BAD—malignant glioma	7.9e-06	4.65e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—BCHE—malignant glioma	7.88e-06	4.64e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	7.86e-06	4.62e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—NOTCH1—malignant glioma	7.82e-06	4.6e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—BCHE—malignant glioma	7.81e-06	4.6e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PPARG—malignant glioma	7.79e-06	4.58e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—SLC5A5—malignant glioma	7.79e-06	4.58e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.75e-06	4.56e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—SLC5A5—malignant glioma	7.72e-06	4.54e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—IDH1—malignant glioma	7.72e-06	4.54e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—GSTT1—malignant glioma	7.66e-06	4.51e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CD80—malignant glioma	7.66e-06	4.51e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—NCOR1—malignant glioma	7.66e-06	4.51e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—APC—malignant glioma	7.65e-06	4.5e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—GSTP1—malignant glioma	7.64e-06	4.5e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PIK3CG—malignant glioma	7.63e-06	4.49e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	7.61e-06	4.48e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PIK3CB—malignant glioma	7.58e-06	4.46e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PIK3CB—malignant glioma	7.58e-06	4.46e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—EGF—malignant glioma	7.56e-06	4.45e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PTGS2—malignant glioma	7.52e-06	4.42e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PTGS2—malignant glioma	7.52e-06	4.42e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—PTPN11—malignant glioma	7.51e-06	4.42e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—SPHK1—malignant glioma	7.47e-06	4.39e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—CAT—malignant glioma	7.43e-06	4.37e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PPARG—malignant glioma	7.36e-06	4.33e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CYP2C18—malignant glioma	7.31e-06	4.3e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.3e-06	4.3e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.23e-06	4.26e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—BRAF—malignant glioma	7.19e-06	4.23e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PTGS1—malignant glioma	7.18e-06	4.23e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	7.16e-06	4.21e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PIK3CD—malignant glioma	7.09e-06	4.17e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—CAV1—malignant glioma	7.03e-06	4.14e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—NCOR1—malignant glioma	7.02e-06	4.13e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—AKT2—malignant glioma	7e-06	4.12e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—PIK3CD—malignant glioma	6.72e-06	3.96e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.72e-06	3.95e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PIK3CD—malignant glioma	6.71e-06	3.95e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—BCHE—malignant glioma	6.68e-06	3.93e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—GSTP1—malignant glioma	6.65e-06	3.92e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—CAV1—malignant glioma	6.62e-06	3.9e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—SLC5A5—malignant glioma	6.6e-06	3.88e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PTEN—malignant glioma	6.55e-06	3.86e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PTEN—malignant glioma	6.55e-06	3.86e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—CAT—malignant glioma	6.48e-06	3.81e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—FGF2—malignant glioma	6.44e-06	3.79e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PIK3CG—malignant glioma	6.41e-06	3.77e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.31e-06	3.71e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—GSTP1—malignant glioma	6.27e-06	3.69e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—CAV1—malignant glioma	6.24e-06	3.67e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.24e-06	3.67e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—GSTP1—malignant glioma	6.22e-06	3.66e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PIK3CB—malignant glioma	6.18e-06	3.64e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PPARG—malignant glioma	6.18e-06	3.64e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.18e-06	3.64e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PTGS2—malignant glioma	6.13e-06	3.61e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—NCOR1—malignant glioma	6.12e-06	3.6e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—CAT—malignant glioma	6.1e-06	3.59e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—CAT—malignant glioma	6.05e-06	3.56e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PIK3CG—malignant glioma	6.03e-06	3.55e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—MDM2—malignant glioma	6.02e-06	3.55e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—RAF1—malignant glioma	6e-06	3.53e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.96e-06	3.51e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—ERBB2—malignant glioma	5.94e-06	3.5e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—GSTT1—malignant glioma	5.92e-06	3.48e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—PIK3CB—malignant glioma	5.86e-06	3.45e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PIK3CB—malignant glioma	5.85e-06	3.44e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PPARG—malignant glioma	5.82e-06	3.43e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PTGS2—malignant glioma	5.79e-06	3.41e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—NCOR1—malignant glioma	5.76e-06	3.39e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—CAV1—malignant glioma	5.72e-06	3.37e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—NCOR1—malignant glioma	5.71e-06	3.36e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PIK3CG—malignant glioma	5.69e-06	3.35e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PIK3CD—malignant glioma	5.63e-06	3.31e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PTGS1—malignant glioma	5.54e-06	3.26e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PPARG—malignant glioma	5.49e-06	3.23e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.47e-06	3.22e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.39e-06	3.17e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PTEN—malignant glioma	5.34e-06	3.14e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—GSTP1—malignant glioma	5.31e-06	3.13e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PIK3CD—malignant glioma	5.3e-06	3.12e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PIK3CG—malignant glioma	5.21e-06	3.07e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—CAT—malignant glioma	5.17e-06	3.04e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—BCHE—malignant glioma	5.15e-06	3.03e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—SLC5A5—malignant glioma	5.09e-06	3e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—PTEN—malignant glioma	5.06e-06	2.98e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PTEN—malignant glioma	5.05e-06	2.97e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PPARG—malignant glioma	5.03e-06	2.96e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PIK3CD—malignant glioma	5e-06	2.94e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—CAV1—malignant glioma	4.99e-06	2.93e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PIK3CB—malignant glioma	4.91e-06	2.89e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—NCOR1—malignant glioma	4.88e-06	2.87e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—CAV1—malignant glioma	4.7e-06	2.76e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—CAV1—malignant glioma	4.66e-06	2.74e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PIK3CA—malignant glioma	4.62e-06	2.72e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PIK3CA—malignant glioma	4.62e-06	2.72e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PIK3CB—malignant glioma	4.62e-06	2.72e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PIK3CD—malignant glioma	4.58e-06	2.7e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PTGS2—malignant glioma	4.58e-06	2.69e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PIK3CG—malignant glioma	4.54e-06	2.67e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—STAT3—malignant glioma	4.53e-06	2.67e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.45e-06	2.62e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PPARG—malignant glioma	4.38e-06	2.58e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PIK3CB—malignant glioma	4.36e-06	2.56e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PTGS2—malignant glioma	4.32e-06	2.54e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PIK3CG—malignant glioma	4.28e-06	2.52e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PIK3CG—malignant glioma	4.24e-06	2.5e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PTEN—malignant glioma	4.24e-06	2.5e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—MYC—malignant glioma	4.21e-06	2.48e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PPARG—malignant glioma	4.13e-06	2.43e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—EGFR—malignant glioma	4.12e-06	2.42e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—GSTP1—malignant glioma	4.1e-06	2.41e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PPARG—malignant glioma	4.09e-06	2.41e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PIK3CB—malignant glioma	3.99e-06	2.35e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PTEN—malignant glioma	3.99e-06	2.35e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PIK3CD—malignant glioma	3.99e-06	2.35e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CAT—malignant glioma	3.99e-06	2.35e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—CAV1—malignant glioma	3.98e-06	2.34e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PTGS2—malignant glioma	3.96e-06	2.33e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—KRAS—malignant glioma	3.89e-06	2.29e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.8e-06	2.24e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—AKT1—malignant glioma	3.78e-06	2.22e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—AKT1—malignant glioma	3.78e-06	2.22e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PIK3CA—malignant glioma	3.77e-06	2.22e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—NCOR1—malignant glioma	3.77e-06	2.22e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PTEN—malignant glioma	3.76e-06	2.22e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PIK3CD—malignant glioma	3.76e-06	2.21e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PIK3CD—malignant glioma	3.73e-06	2.19e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PIK3CG—malignant glioma	3.63e-06	2.13e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—PIK3CA—malignant glioma	3.57e-06	2.1e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PIK3CA—malignant glioma	3.56e-06	2.1e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PPARG—malignant glioma	3.5e-06	2.06e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PIK3CB—malignant glioma	3.48e-06	2.05e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PTEN—malignant glioma	3.45e-06	2.03e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PTGS2—malignant glioma	3.45e-06	2.03e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PIK3CB—malignant glioma	3.28e-06	1.93e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PIK3CB—malignant glioma	3.25e-06	1.91e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PTGS2—malignant glioma	3.25e-06	1.91e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PTGS2—malignant glioma	3.22e-06	1.9e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PIK3CD—malignant glioma	3.19e-06	1.88e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—AKT1—malignant glioma	3.08e-06	1.81e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CAV1—malignant glioma	3.07e-06	1.81e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PTEN—malignant glioma	3.01e-06	1.77e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PIK3CA—malignant glioma	2.99e-06	1.76e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—AKT1—malignant glioma	2.92e-06	1.72e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—AKT1—malignant glioma	2.91e-06	1.71e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PTEN—malignant glioma	2.83e-06	1.67e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PIK3CA—malignant glioma	2.82e-06	1.66e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PTEN—malignant glioma	2.81e-06	1.65e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.8e-06	1.65e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PIK3CB—malignant glioma	2.78e-06	1.63e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PTGS2—malignant glioma	2.75e-06	1.62e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PPARG—malignant glioma	2.7e-06	1.59e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PIK3CA—malignant glioma	2.66e-06	1.56e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.46e-06	1.45e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—AKT1—malignant glioma	2.44e-06	1.44e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PIK3CA—malignant glioma	2.43e-06	1.43e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PTEN—malignant glioma	2.4e-06	1.41e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—AKT1—malignant glioma	2.3e-06	1.35e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—AKT1—malignant glioma	2.17e-06	1.28e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.14e-06	1.26e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PTGS2—malignant glioma	2.12e-06	1.25e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PIK3CA—malignant glioma	2.12e-06	1.25e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PIK3CA—malignant glioma	2e-06	1.18e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—AKT1—malignant glioma	1.99e-06	1.17e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.98e-06	1.17e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PTEN—malignant glioma	1.85e-06	1.09e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—AKT1—malignant glioma	1.73e-06	1.02e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.69e-06	9.97e-06	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—AKT1—malignant glioma	1.63e-06	9.61e-06	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—AKT1—malignant glioma	1.62e-06	9.53e-06	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—AKT1—malignant glioma	1.38e-06	8.14e-06	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.31e-06	7.69e-06	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—AKT1—malignant glioma	1.07e-06	6.28e-06	CbGpPWpGaD
